Loading ...

Siplizumab for Liver Transplant Tolerance

(

PEARL

)

ITN Protocol #:

ITN100ST

Branded Name:

PEARL

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Transplantation

Current Status:

Development

Summary:

Promoting Exhaustion and Regulation in in Liver Transplantation using Siplizumab

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

Study Personnel:

Protocol Chair

Audrey Ploughaplough@immunetolerance.org

Work: 

415-278-0709

Protocol Chair

Geo Gaileggaile@immunetolerance.org

Work: 

415-854-7485

Protocol Chair

Cynthia Breeden, MPHcbreeden@immunetolerance.org

Work: 

404-379-5811

Protocol Chair

Sindhu Chandran, MDschandran@immunetolerance.org

Work: 

415-610-4284